Literature DB >> 31993363

Recombinant activated factor seven in pediatric cardiac surgery-does thrombotic risk outweigh hemostatic benefit?

John P Scott1.   

Abstract

Year:  2019        PMID： 31993363      PMCID： PMC6970117          DOI： 10.21037/tp.2019.10.04

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  14 in total

1.  Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.

Authors:  Kathryn A O'Connell; Jennifer J Wood; Robert P Wise; Jay N Lozier; M Miles Braun
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

2.  Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation.

Authors:  Robert A Niebler; Rowena C Punzalan; Marisela Marchan; Michael W Lankiewicz
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

3.  Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.

Authors:  Laura Downey; Morgan L Brown; David Faraoni; David Zurakowski; James A DiNardo
Journal:  Anesth Analg       Date:  2017-05       Impact factor: 5.108

4.  Relationship Between Transfusion of Blood Products and the Incidence of Thrombotic Complications in Neonates and Infants Undergoing Cardiac Surgery.

Authors:  David Faraoni; Sirisha Emani; Erin Halpin; Rachel Bernier; Sitaram M Emani; James A DiNardo; Juan C Ibla
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-04-27       Impact factor: 2.628

5.  Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery.

Authors:  Cedric Manlhiot; Ines B Menjak; Leonardo R Brandão; Colleen E Gruenwald; Steven M Schwartz; V Ben Sivarajan; Hyaemin Yoon; Robert Maratta; Caitlin L Carew; Janet A McMullen; Nadia A Clarizia; Helen M Holtby; Suzan Williams; Christopher A Caldarone; Glen S Van Arsdell; Anthony K Chan; Brian W McCrindle
Journal:  Circulation       Date:  2011-09-12       Impact factor: 29.690

Review 6.  Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.

Authors:  Nina A Guzzetta; Isobel A Russell; Glyn D Williams
Journal:  Anesth Analg       Date:  2012-05-31       Impact factor: 5.108

7.  Recombinant activated factor VII following pediatric cardiac surgery.

Authors:  Sharmila Kylasam; Krista Mos; Stephanie Fijtin; Boyd Webster; Richard Chard; Jonathan Egan
Journal:  J Intensive Care Med       Date:  2009-02-02       Impact factor: 3.510

Review 8.  Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?

Authors:  Oliver J Warren; Paula L B Rogers; Amy L Watret; Katie L de Wit; Ara W Darzi; Ravi Gill; Thanos Athanasiou
Journal:  Pediatr Crit Care Med       Date:  2009-09       Impact factor: 3.624

9.  Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.

Authors:  Hemant S Agarwal; Jo E Bennett; Kevin B Churchwell; Karla G Christian; Davis C Drinkwater; Yi He; Mary B Taylor
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

10.  Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.

Authors:  Todd J Karsies; Kathleen K Nicol; Mark E Galantowicz; Julie A Stephens; Bryce A Kerlin
Journal:  Ann Thorac Surg       Date:  2010-02       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.